1. Radioiodine – the success story of Nuclear Medicine

   • V. Ralph McCready

   Editorial 19 October 2016 Pages: 179 - 182

2. Adjuvant post-operative I-131 therapy in differentiated thyroid carcinoma: are the 2015 ATA guidelines an exact science or a dark art?

   • Frederik A. Verburg
   • Markus Luster
   • Luca Giovanella

   Editorial Commentary 10 October 2016 Pages: 183 - 184

3. Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients

   • Savvas Frangos
   • Ioannis P. Iakovou
   • Evanthia I. Giannoula

   Short Communication 25 August 2016 Pages: 185 - 189

4. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma

   • Amir Sabet
   • Ina Binse
   • Samer Ezziddin

   Original Article 16 August 2016 Pages: 190 - 195

   

5. Predictive medicine: towards a multi-parametric imaging for a personal risk stratification

   • Eric Guedj
   • Serge Cammilleri
   • Antoine Verger

   Editorial Commentary 27 September 2016 Pages: 196 - 198

6. Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary: identification of the best benefited patients

   • Yifei Ma
   • Wei Xu
   • Jianru Xiao

   Original Article 07 September 2016 Pages: 199 - 205

   

7. Texture analysis of ¹⁸F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy

   • Masatoyo Nakajo
   • Megumi Jinguji
   • Takashi Yoshiura

   Original Article 10 September 2016 Pages: 206 - 214

   

8. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas

   • Emanuela Palmerini
   • Marco Colangeli
   • Stefano Ferrari

   Original Article Open access 20 September 2016 Pages: 215 - 223

   

9. Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT

   • Pierpaolo Alongi
   • Federico Caobelli
   • Massimo Midiri

   Original Article 26 August 2016 Pages: 224 - 233

   

10. ¹²³I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel

    • V. Lewington
    • B. Lambert
    • R. Ladenstein

    Original Article Open access 24 September 2016 Pages: 234 - 241

    

11. Lymphocyte function following radium-223 therapy in patients with metastasized, castration-resistant prostate cancer

    • Vahé Barsegian
    • Stefan P. Müller
    • Monika Lindemann

    Original Article 08 October 2016 Pages: 242 - 246

    

12. Do we need FDG-PET/CT to assess atherosclerosis?

    • Nicolò Pipitone
    • Carlo Salvarani
    • Annibale Versari

    Editorial Commentary 18 November 2016 Pages: 247 - 248

13. Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study

    • Björn A. Blomberg
    • Pim A. de Jong
    • Poul F. Høilund-Carlsen

    Original Article Open access 29 October 2016 Pages: 249 - 258

    

14. Clinical values of left ventricular mechanical dyssynchrony assessment by gated myocardial perfusion SPECT in patients with acute myocardial infarction and multivessel disease

    • Sang-Geon Cho
    • Zeenat Jabin
    • Hee-Seung Bom

    Original Article 18 October 2016 Pages: 259 - 266

    

15. The natural history of takotsubo syndrome: a two-year follow-up study with myocardial sympathetic and perfusion G-SPECT imaging

    • Stelvio Sestini
    • Francesco Pestelli
    • Antonio Castagnoli

    Original Article 01 December 2016 Pages: 267 - 283

    

16. Editorial European Journal of Nuclear Medicine and Molecular Imaging

    • Ambros J. Beer
    • Ingrid Dijkgraaf

    Editorial Commentary Open access 07 November 2016 Pages: 284 - 285

17. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for ⁸⁹Zr-immuno-PET

    • Danielle J. Vugts
    • Chris Klaver
    • Guus A. M. S. van Dongen

    Original Article Open access 30 August 2016 Pages: 286 - 295

    

18. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [¹⁸F]PBR102 and [¹⁸F]PBR111

    • S. Eberl
    • A. Katsifis
    • M. J. Fulham

    Original Article 04 October 2016 Pages: 296 - 307

    

19. Characterization of [¹¹C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain

    • Kai-Chun Yang
    • Vladimir Stepanov
    • Sjoerd J. Finnema

    Original Article Open access 05 November 2016 Pages: 308 - 320

    

20. ¹⁸F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with ¹⁸F-FDG and ¹¹C-Methionine PET

    • Tadashi Watabe
    • Hayato Ikeda
    • Jun Hatazawa

    Original Article 22 August 2016 Pages: 321 - 331

    

21. Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting

    • Esther G. M. de Waal
    • Andor W. J. M. Glaudemans
    • Riemer H. J. A. Slart

    Review Article Open access 29 November 2016 Pages: 332 - 341

    

22. Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma

    • Hugo J. A. Adams
    • Thomas C. Kwee

    Letter to the Editor 25 October 2016 Pages: 342 - 343

23. Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma

    • Federico Fallanca
    • Pierpaolo Alongi
    • Jamshed B. Bomanji

    Reply 28 October 2016 Pages: 344 - 345

24. The delicate balance between present and future

    • Marco Spadafora
    • Leonardo Pace
    • Luigi Mansi

    Letter to the Editor 01 December 2016 Pages: 346 - 347

25. ⁶⁸Ga-PSMA PET/CT with MRI fusion: spinal cord metastasis from prostate cancer

    • Werner Langsteger
    • Friedrich Fitz
    • Mohsen Beheshti

    Image of the Month 27 October 2016 Pages: 348 - 349

    

26. Brain perfusion SPECT for brain death assessment

    • Pedro Barata Silva Coelho
    • Ana Fernandes
    • Jorge Pereira

    Image of the Month 16 November 2016 Pages: 350 - 351

    

27. Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with ¹⁷⁷Lu-D OTATATE

    • Maddalena Sansovini
    • Stefano Severi
    • Giovanni Paganelli

    Erratum 02 November 2016 Pages: 352 - 352